You searched for "Retinal"
Comparison of retinal pigment epithelium-choroid graft surgery and anti-VEGF therapy in patients with wet AMD
1 December 2015
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This was a randomised intervention study in wet AMD patients to investigate benefits of free RPE-choroid graft transplantation surgery versus (continuation of) anti-VEGF treatment. Twenty patients who met the inclusion criteria were subdivided into three subgroups, i.e. RPE tears involving...
Can coenzyme Q10 have a protective role in ethambutol-induced retinal ganglion cell toxicity
3 April 2023
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Ethambutol, coenzyme Q10, ethambutol toxic optic neuropathy, retinal ganglion cells, tuberculosis
Tuberculosis (TB) is one of the most prevalent infectious diseases, especially in developing or low- income countries. Ethambutol is a widely used drug to treat TB. Ethambutol can cause visual disturbance including ethambutol toxic optic neuropathy (ETON). ETON is one...
Chandelier-assisted versus standard scleral buckling for rhegmatogenous retinal detachment repair. Systematic review and meta-analysis
4 December 2024
| Sofia Rokerya
|
EYE - Vitreo-Retinal
Despite a significant global decline in standard scleral buckling (SSB) procedures for rhegmatogenous retinal detachment (RRD), it continues to hold its place as an essential treatment option, offering distinct advantages such as cost-effectiveness, preservation of the vitreous, improved final visual...
Outcomes at 100 weeks from the LEAVO study of intravitreal anti-VEGF therapies for macular oedema secondary to central retinal vein occlusion
23 May 2019
| Rod McNeil
Royal College of Ophthalmologists Annual Congress 2019, Glasgow - First presented and discussed on Monday 20 May 2019, with a further presentation of results during Retina Subspecialty Day on Thursday 23 May 2019. Among patients with macular oedema secondary to...
Outcomes following repair of early-onset versus delayed-onset rhegmatogenous retinal detachments (RD) after acute posterior vitreous detachment (PVD)
2 August 2024
| Jonathan Chan
|
EYE - Vitreo-Retinal
This is a retrospective single centre comparative interventional study of 210 patients in total, between 2015 to 2020, presenting with delayed RD (diagnosed >42 days after initial acute PVD presentation) compared with a 2:1 age and gender-matched acute RD cohort...
Persistent subretinal fluid (PSFF) in pneumatic retinopexy (PNR) versus pars plana vitrectomy (PPV) for rhegmatogenous retinal detachment (RRD): posthoc analysis of the PIVOT randomised trial
10 May 2024
| Jonathan Chan
|
EYE - Vitreo-Retinal
This is a posthoc study of the PIVOT randomised trial over a 12 month period, to evaluate the functional outcomes of the incidence of PSF in PnR versus PPV following RRD surgery. One hundred and fifty-eight patients were recruited and...
Moorfields to start new retinal detachment clinical trial
8 November 2023
|
Moorfields, Funding, Phase I trial, Mahi Muqit, retinal detachment, proliferative vitreoretinopathy
Moorfields to start new retinal detachment clinical trial following £1.2 million MRC DPFS grant awarded to UCL and Moorfields Eye Hospital.
RSM (The Royal Society of Medicine): Update on retinal disorders
18 May 2023
Join this virtual meeting to gain an update from experts in the field, this webinar will provide general ophthalmologists as well as those with interest in retinal disorders with an informative update on retinal disease. The aim of this meeting...
3rd Annual Retinal Imaging Biomarkers & Endpoints Summit
27 May 2025
-29 May 2025
Accelerate Your Ophthalmic Development with Deep Learning Systems & Sophisticated AI Imaging TechnologiesWith state-of-the-art AI-assisted technology making retinal imaging 100 times faster, the rapid advancement of technology in ophthalmology, coupled with the strong unmet need for more drugs for retinal...
